---
category: news
title: "Roivant extends AI drug discovery reach with $450M Silicon Therapeutics buyout"
excerpt: "Roivant Sciences is expanding its drug discovery and design capabilities via a stock deal to acquire Silicon Therapeutics. The Boston startup uses physics-based modeling to simulate proteins and the small molecules that bind to them."
publishedDateTime: 2021-02-26T20:35:00Z
originalUrl: "https://medcitynews.com/2021/02/roivant-extends-ai-drug-discovery-reach-with-450m-silicon-therapeutics-buyout/"
webUrl: "https://medcitynews.com/2021/02/roivant-extends-ai-drug-discovery-reach-with-450m-silicon-therapeutics-buyout/"
type: article
quality: 33
heat: 33
published: false

provider:
  name: MedCity News
  domain: medcitynews.com

topics:
  - AI

images:
  - url: "https://medcitynews.com/uploads/2021/02/GettyImages-1093880948.jpg"
    width: 724
    height: 483
    isCached: true

secured: "p9WYOSyYJGwGOtK0M2nou0znOnz+zrqxHJMJq4hbF1+lUhuGwwvd6IZP0wtfUxVCuiJSbZOq+hW+++Eglq6IYX8swn7SUGNk3TTljjzrhhr/fBVfY960k4ol8zG91KojDZBYzyRB6MPp1Dva9nANa2g8J8eN2A6I+zzvB7QWV/FTm6dLy00OUa32NOH4ijJhCTFBNrvw36ae8/dWTQ6RWG3QxgQT4QYYj/PKETMoFy8cM+2yzJGUVhMstA9GZhQ8mG1yIN1c9S0EjF+2iVI7kcgMTc/SDPv9l7vMuYDxNymPLImwd6sTKAUnmNrGlVqNDh1Z0K7qbi0aWBNJmessIJeKRgHOjaOHaMFzoHIoTSk=;SDEGxgkydXQZXzHmv7/HPg=="
---

